Marvel Biosciences secures funding from 5 Horizons Ventures for Phase I trial of MB-204, aimed at treating autism and related conditions.
Round Type
Funding Round
Investors
Description
Marvel Biosciences has received financial and strategic investment from 5 Horizons Ventures for its Phase I clinical trial of the lead drug candidate, MB-204. The Phase 1 program aims to evaluate MB-204's potential in treating neurodevelopmental disorders. With this partnership, Marvel intends to leverage 5 Horizons' resources to accelerate development. This initiative will reduce capital requirements while advancing human clinical studies.
Quick answer
Marvel Biosciences raised an undisclosed amount in a Funding Round round, dated April 7, 2026. Investors: 5 Horizons Ventures.
- How much did Marvel Biosciences raise?
- Marvel Biosciences raised an undisclosed amount in a Funding Round round on April 7, 2026.
- Who invested in Marvel Biosciences?
- 5 Horizons Ventures is named as investors in this round.
- What does Marvel Biosciences do?
- Marvel Biosciences Corp., through its wholly owned subsidiary Marvel Biotechnology Inc., is a Calgary-based biotechnology company developing new treatments for neurological diseases and neurodevelopmental disorders.
- Where is Marvel Biosciences based and how big is it?
- Fundz records about 5 employees.
- Who are the decision-makers at Marvel Biosciences?
- Fundz holds 1 contact at Marvel Biosciences, including the CEO & Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Marvel Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Kordata Dynamics raised an undisclosed amount (Pre-Seed) on May 21, 2026.
- HCW Biologics raised $4M on May 21, 2026.
- AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
- Forlong Biotechnology raised $18M (Funding Round) on May 19, 2026.
- ProEncia Biotechnology raised an undisclosed amount (Pre-Seed) on May 19, 2026.
- Wonderlab Bio raised an undisclosed amount on May 18, 2026.
Who to call at Marvel Biosciences, and when
A new round usually means Marvel Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Marvel Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Marvel Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Marvel Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Marvel Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Marvel Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.